JPET

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Aguayo, L. G.
Right arrow Articles by Grossie, J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Aguayo, L. G.
Right arrow Articles by Grossie, J.

Dopamine inhibits a sustained calcium current through activation of alpha adrenergic receptors and a GTP-binding protein in adult rat sympathetic neurons

LG Aguayo and J Grossie

Section of Electrophysiology, National Institute on Alcohol Abuse and Alcoholism, Rockville, Maryland.

Although it is suspected that dopamine (DA) inhibits a Ca++ current in sympathetic neurons, the receptor and the Ca++ channel type involved are still unknown. We found that DA caused a reversible inhibition on omega-conotoxin sensitive and resistant Ca++ currents in the superior cervical ganglion (SCG). The concentration of DA that induced half- maximal inhibition was 3.0 microM. The DA receptor agonists (+/-)-SKF- 38393 (D1 type) and quinpirole (D2 type) appeared unable to induce an inhibition of the Ca++ current. Furthermore, the receptor antagonists SCH-23390 (D1 type) and (-)-sulpiride (D2 type) did not prevent the inhibitory effect of DA. This suggests that the effect of DA on the Ca++ current was not due to activation of DA receptors. The inhibition of the Ca2++ current by DA was reduced by application of 1 microM phentolamine, a nonselective alpha adrenergic antagonist, and by prazosin and yohimbine, alpha-1 and alpha-2 receptor antagonists, respectively. The beta adrenergic receptor antagonist propranolol did not block the effect of DA. A guanine nucleotide-binding protein appears to be involved in the activation of adrenergic receptors by DA. The addition of GTP-gamma-S (0.1 mM) to the intracellular solution produced an effect similar to that of DA. Incubation of sympathetic neurons with pertussis toxin reduced the effect of DA by 90%. The results indicate that DA reduces the number of available Ca++ channels in sympathetic neurons by activation of alpha adrenergic receptors, which are associated with a pertussis-sensitive GTP-binding protein.

Volume 269, Issue 2, pp. 503-508, 05/01/1994
Copyright © 1994 by American Society for Pharmacology and Experimental Therapeutics




This article has been cited by other articles:


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
G. Ding, R. F. Wiegerinck, M. Shen, A. Cojoc, C. M. Zeidenweber, and M. B. Wagner
Dopamine increases L-type calcium current more in newborn than adult rabbit cardiomyocytes via D1 and {beta}2 receptors
Am J Physiol Heart Circ Physiol, May 1, 2008; 294(5): H2327 - H2335.
[Abstract] [Full Text] [PDF]


Home page
J. Neurosci.Home page
C. A. Cornil, J. Balthazart, P. Motte, L. Massotte, and V. Seutin
Dopamine Activates Noradrenergic Receptors in the Preoptic Area
J. Neurosci., November 1, 2002; 22(21): 9320 - 9330.
[Abstract] [Full Text] [PDF]


Home page
J. Neurophysiol.Home page
J. Behr, T. Gloveli, D. Schmitz, and U. Heinemann
Dopamine Depresses Excitatory Synaptic Transmission Onto Rat Subicular Neurons Via Presynaptic D1-Like Dopamine Receptors
J Neurophysiol, July 1, 2000; 84(1): 112 - 119.
[Abstract] [Full Text] [PDF]


Home page
J. Neurosci.Home page
N. A. Otmakhova and J. E. Lisman
Dopamine Selectively Inhibits the Direct Cortical Pathway to the CA1 Hippocampal Region
J. Neurosci., February 15, 1999; 19(4): 1437 - 1445.
[Abstract] [Full Text] [PDF]




Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 1994 by the American Society for Pharmacology and Experimental Therapeutics.